Highlights Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

End-of-day quote Swiss Exchange Other stock markets 06:00:00 2024-07-10 pm EDT			5-day change	1st Jan Change
1.18 ^CHF	0.00%		-0.84%	-40.70%

Jun. 03	Relief Therapeutics Holding Announces Term Expiration of Michelle Lock as Interim Chief Executive Officer	CI
Jun. 03	Relief Therapeutics Holding Announces Michelle Lock Will Not Stand for Re-Election as A Member of the Board of Directors	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	Apr. 30	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Mar. 22	MT
Sector Update: Health Care	Mar. 22	MT
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	Mar. 22	MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	Mar. 22	MT
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	Mar. 22	CI
Relief Therapeutics Meets Outstanding ADR Requirement for Nasdaq Listing	23-10-10	MT
Relief Therapeutics Holding AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-15	CI
Relief Therapeutics Posts Wider H1 Loss; Revenue Down	23-09-15	MT
Relief Therapeutics Sells License for Urea Cycle Disorder Drug to Acer Therapeutics	23-08-31	MT
Relief Therapeutics Holding AG Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics	23-08-30	CI
Relief Therapeutics Announces Extension of Distribution Agreement for Pku Golike®? in the U.S. with Pentec Health	23-07-19	CI
Relief Therapeutics Extends US Distribution Deal with Pentec Health for PKU GOLIKE	23-07-19	MT
SIX Group Makes Index Adjustments Following Review	23-07-11	MT
Relief Therapeutics Entrusts Middle Eastern Distribution of PKU GOLIKE to World Orphan Drug Alliance	23-06-23	MT
Swiss Bourse Fines Relief Therapeutics for Delayed Publication of Ad Hoc Announcements	23-06-13	MT
Relief Therapeutics Laboratory Receives Swissmedic Certification for Good Manufacturing Practice	23-05-15	MT
Reverse Split: 1 of 400	23-05-04	FA
Relief Therapeutics to Submit Updated Provisional Patent Application for Lung Disease Drug	23-04-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

Highlights

Filters